Exai Bio

Exai Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Exai Bio is a next-generation liquid biopsy company. Our mission is to enable a world where cancer can be detected early, diagnosed accurately, treated in a personalized and targeted way, and ultimately cured. The company’s proprietary RNA and artificial intelligence-based liquid biopsy platform delivers clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer. Exai Bio was founded with technology from the UCSF laboratory of Dr. Hani Goodarzi, and consists of veteran leaders in the RNA biology, liquid biopsy, and artificial intelligence/machine learning fields from both academia (UCSF, Stanford, MIT) and industry (Bluestar, CareDx, Evidation, Google, 23andMe, Deep Genomics). Exai Bio is supported by leading life sciences and tech investors including Section 32, Casdin Capital, and Two Sigma Ventures, who have been integral to advancing cancer diagnostics, and artificial intelligence and machine learning technologies. We know that people are our greatest asset and we are rapidly building a rock-star team of talent. Our people are driven by the mission, inspired by the vision of the future, and are committed to living our core values (integrity, openness, teamwork, exploration, and kindness) that connect us to our work and to one another. What We Value Our core values represent what we stand for as a team. This is what we believe in. Everyday, we strive to align our behaviors to these core values in everything we do. Integrity – Our thoughts and actions are true to science and to people. We do the right thing. Openness – We recognize and respect our differences – and embrace learning from them. Teamwork – We are team players who trust and respect each other. Exploration – We are explorers, putting curiosity into action. Kindness – We are kind whenever possible – and we believe it’s always possible.

Company Details

Employees
26
Founded
-
Address
3350 W Bayshore Rd, Palo Alto,california 94303,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Palo Alto, California
Looking for a particular Exai Bio employee's phone or email?

Exai Bio Questions

News

Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform - Business Wire

Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform Business Wire

Liquid biopsy market flooded with opportunity - BioWorld MedTech

Liquid biopsy market flooded with opportunity BioWorld MedTech

Deep generative AI models analyzing circulating orphan non-coding RNAs enable detection of early-stage lung cancer - Nature

Deep generative AI models analyzing circulating orphan non-coding RNAs enable detection of early-stage lung cancer Nature

More Evidence Linking Firefighting to Increased Cancer Mortality Risk - MedPage Today

More Evidence Linking Firefighting to Increased Cancer Mortality Risk MedPage Today

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers Fierce Biotech

Exai’s RNA-Based Test Scores in Early Detection for Multiple Cancers - Inside Precision Medicine

Exai’s RNA-Based Test Scores in Early Detection for Multiple Cancers Inside Precision Medicine

Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team - Business Wire

Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team Business Wire

New Genetic Test May Predict Response to Immunotherapy in Triple-Negative Breast Cancer - The ASCO Post

New Genetic Test May Predict Response to Immunotherapy in Triple-Negative Breast Cancer The ASCO Post

Dr. Marra Francis Joins Genece Health as Chief Medical Officer - Yahoo Finance

Dr. Marra Francis Joins Genece Health as Chief Medical Officer Yahoo Finance

Digital Health in Oncology – Emerging Opportunities Across the Cancer Patient Journey - MedCity News

Digital Health in Oncology – Emerging Opportunities Across the Cancer Patient Journey MedCity News

Section 32: Oversubscribed $525 Million Fund 5 Closed - Pulse 2.0

Section 32: Oversubscribed $525 Million Fund 5 Closed Pulse 2.0

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly? - ASCO Publications

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly? ASCO Publications

American Cancer Society Adds Four New Members To Its Board Of Directors - citybiz

American Cancer Society Adds Four New Members To Its Board Of Directors citybiz

Biotech firm Recursion to buy smaller peer Exscientia for $688 million - Reuters

Biotech firm Recursion to buy smaller peer Exscientia for $688 million Reuters

Early Money: A startup that's developed a robot that bores tunnels with heat raised a $30M Series A - The Business Journals

Early Money: A startup that's developed a robot that bores tunnels with heat raised a $30M Series A The Business Journals

Optimistic Investors Push Expert.ai S.p.A. (BIT:EXAI) Shares Up 28% But Growth Is Lacking - simplywall.st

Optimistic Investors Push Expert.ai S.p.A. (BIT:EXAI) Shares Up 28% But Growth Is Lacking simplywall.st

Autechre — Exai - The Quietus

Autechre — Exai The Quietus

Exscientia Plc (EXAI): A Penny Stock That Will Make You a Millionaire - Yahoo Finance

Exscientia Plc (EXAI): A Penny Stock That Will Make You a Millionaire Yahoo Finance

Harbinger’s $140M fundraising bodes well for massive study of its MCED test - BioWorld MedTech

Harbinger’s $140M fundraising bodes well for massive study of its MCED test BioWorld MedTech

Genetic Technologies’ Genetype test detects early risk for multiple diseases - BioWorld MedTech

Genetic Technologies’ Genetype test detects early risk for multiple diseases BioWorld MedTech

Autechre : Exai - treblezine.com

Autechre : Exai treblezine.com

Autechre: Exai Album Review - Pitchfork

Autechre: Exai Album Review Pitchfork

Album Review: Autechre – Exai - beatsperminute.com

Album Review: Autechre – Exai beatsperminute.com

Review: Autechre, 'Exai' - Slant Magazine

Review: Autechre, 'Exai' Slant Magazine

Album Review: Autechre - Exai - // Drowned In Sound

Album Review: Autechre - Exai // Drowned In Sound

Review: Autechre: Exai - Inverted Audio

Review: Autechre: Exai Inverted Audio

Top Exai Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant